Interstitial Nephritis in a Patient with Inflammatory Bowel Disease

Interstitial Nephritis in a Patient with Inflammatory Bowel Disease

Tubulointerstitial nephritis in patients with inflammatory bowel disease has been linked to the use of 5-ASA derivatives. Various aspects of this theory have been challenged with a potential role for the underlying autoimmune disorder. Steroids are the mainstay of treatment and mycophenolate mofetil...

Full description

Bibliographic Details
Main Authors: Payaswini Vasanth, Michelle Parmley, Jose Torrealba, Tamim Hamdi
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Case Reports in Nephrology
Online Access:http://dx.doi.org/10.1155/2016/4260365
id doaj-becfd60c6f824288af78408e9d938b15
record_format Article
spelling doaj-becfd60c6f824288af78408e9d938b152020-11-24T22:09:59ZengHindawi LimitedCase Reports in Nephrology2090-66412090-665X2016-01-01201610.1155/2016/42603654260365Interstitial Nephritis in a Patient with Inflammatory Bowel DiseasePayaswini Vasanth0Michelle Parmley1Jose Torrealba2Tamim Hamdi3Department of Internal Medicine, Division of Nephrology, UT Southwestern Medical Center, Dallas, TX, USADepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USADepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USADepartment of Internal Medicine, Division of Nephrology, UT Southwestern Medical Center, Dallas, TX, USATubulointerstitial nephritis in patients with inflammatory bowel disease has been linked to the use of 5-ASA derivatives. Various aspects of this theory have been challenged with a potential role for the underlying autoimmune disorder. Steroids are the mainstay of treatment and mycophenolate mofetil might be an effective alternative. We report a patient who responded well to mycophenolate despite continuing mesalamine, the suspected offending agent.http://dx.doi.org/10.1155/2016/4260365
collection DOAJ
language English
format Article
sources DOAJ
author Payaswini Vasanth
Michelle Parmley
Jose Torrealba
Tamim Hamdi
spellingShingle Payaswini Vasanth
Michelle Parmley
Jose Torrealba
Tamim Hamdi
Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
Case Reports in Nephrology
author_facet Payaswini Vasanth
Michelle Parmley
Jose Torrealba
Tamim Hamdi
author_sort Payaswini Vasanth
title Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
title_short Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
title_full Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
title_fullStr Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
title_full_unstemmed Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
title_sort interstitial nephritis in a patient with inflammatory bowel disease
publisher Hindawi Limited
series Case Reports in Nephrology
issn 2090-6641
2090-665X
publishDate 2016-01-01
description Tubulointerstitial nephritis in patients with inflammatory bowel disease has been linked to the use of 5-ASA derivatives. Various aspects of this theory have been challenged with a potential role for the underlying autoimmune disorder. Steroids are the mainstay of treatment and mycophenolate mofetil might be an effective alternative. We report a patient who responded well to mycophenolate despite continuing mesalamine, the suspected offending agent.
url http://dx.doi.org/10.1155/2016/4260365
work_keys_str_mv AT payaswinivasanth interstitialnephritisinapatientwithinflammatoryboweldisease
AT michelleparmley interstitialnephritisinapatientwithinflammatoryboweldisease
AT josetorrealba interstitialnephritisinapatientwithinflammatoryboweldisease
AT tamimhamdi interstitialnephritisinapatientwithinflammatoryboweldisease
_version_ 1725809756288843776

Similar Items